PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation

Background. Natalizumab treatment is frequently discontinued and replaced by alternative medication in multiple sclerosis (MS) patients having a high risk of progressive multifocal leukoencephalopathy (PML). Case Presentation. We report a PML case that was missed on magnetic resonance imaging (MRI)...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Case Rep Neurol Med
Main Authors: Killestein, J., Vennegoor, A., van Golde, A. E. L., Bourez, R. L. J. H., Wijlens, M. L. B., Wattjes, M. P.
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2014
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4258922/
https://ncbi.nlm.nih.gov/pubmed/25506447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/307872
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki